Literature DB >> 30811696

Overview on vitamin D and sunbed use.

L Pierret1, M Suppa2, S Gandini3, V Del Marmol2, J Gutermuth1.   

Abstract

Vitamin D seems to be associated with a protective effect in a vast range of diseases, including cardiovascular, autoimmune and oncologic conditions. Since ultraviolet (UV) B light is the most important prerequisite for the cutaneous synthesis of vitamin D, sunbeds are able to increase serum vitamin D levels, although only transiently in most cases. In this scenario, the artificial tanning industry relentlessly tries to promote the use of sunbeds as a 'safe' therapeutic measure to achieve an adequate serum vitamin D status. The World Health Organization classified UV-emitting tanning devices, as well as the whole UV spectrum, as group-1 carcinogens, as they significantly increase the risk of melanoma and non-melanoma skin cancer. In case of vitamin D deficiency or insufficiency, the current risk-benefit ratio is therefore in favour of vitamin D supplementation instead of sunbed use. Artificial tanning devices should never be considered as an option to achieve an appropriate vitamin D status. Their supposedly beneficial effects, vastly publicised by the artificial tanning industry, are not worth the carcinogenic risk associated with sunbed use.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30811696     DOI: 10.1111/jdv.15316

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

1.  Prevalence of Vitamin-D deficiency is related to severity of liver damage in Hepatitis-C patients.

Authors:  Sadia Falak; Lubna Aftab; Muhammad Saeed; Aftab Islam
Journal:  Pak J Med Sci       Date:  2020 Mar-Apr       Impact factor: 1.088

Review 2.  Vitamin D and Skin Cancer: An Epidemiological, Patient-Centered Update and Review.

Authors:  Alejandro Martin-Gorgojo; Yolanda Gilaberte; Eduardo Nagore
Journal:  Nutrients       Date:  2021-11-28       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.